Pancreatic Stellate Cells Aggravate Pain in Pancreatic Cancer Through Hedgehog Signaling Pathway
Liang Han,Wei Li,Wanxing Duan,Shuo Yu,Chao Chen,Lun Zhang,Qinhong Xu,Jianjun Lei,Qingyong Ma
DOI: https://doi.org/10.1093/annonc/mdt203.36
IF: 51.769
2013-01-01
Annals of Oncology
Abstract:Background: Sonic hedgehog (SHH) has been associated with the progression pancreatic cancer (PC), which impact upon proliferation, invasion and metastasis. The development of pancreatic fibrosis, in which pancreatic stellate cells (PSC) play the especially active role, has been shown to be a major component in PC. To evaluate the role of the channel in producing pain in PC, we studied the dorsal root ganglion (DRG), PC cells and PSC in co-culture models of PC in vitro. Methods: The co-culture models were divided into 3 groups: A: PC cell line Panc-1 and DRG; B: PSC and DRG; C: Panc-1, PSC and DRG. The TRPV1 channel expression were detected by western blot, and the function and excitability of TRPV1 were determined by patch clamp in DRG. The expression of neurotrophic factors (NGF, GDNF, BDNF) which could regulate TRPV1, and pain-related factors (sp, CGRP) were evaluated by realtime-PCR, western blot and ELISA, respectively. The SHH signaling inhibitor cyclopamine (2 µmol/L) was employed in the system. Results: The increased excitability and messenger RNA or protein expression of TRPV1 in DRG were more remarkable in group C than A and B. In the system of group C, DRG liberate more CGRP and SP, respectively. Production of neurotrophic factors in co-culture system of group C demonstrated a 12-fold increase on NGF, 7-fold increase on GDNF, and 5-fold increase on BDNF contrast to group A, suggesting the positive effect of PSC in the co-culture system. In addition, Systemic administration of the SHH signaling passage antagonist cyclopamine in Group C, the expression of neurotrophic factors were remarkably inhibited, and the function or excitability of TRPV1 was decreased in the co-culture system. Conclusion: In the co-culture system of Panc-1, PSC and DRG, the expression and function of TRPV1 and neurotrophic factors significantly increased, as well as the massive release of sp and CGRP. Moreover, SHH channel antagonists acted to reverse the excitability and expression of TRPV1 and neurotrophic factors, synergistically down-regulated the pain-related factors. Reagents which target SHH channels might be developed to reduce pain in PC patients.